TY - JOUR
T1 - Osteogenesis imperfecta type V
T2 - Marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients
AU - Rauch, Frank
AU - Moffatt, Pierre
AU - Cheung, Moira
AU - Roughley, Peter
AU - Lalic, Liljana
AU - Lund, Allan M.
AU - Ramirez, Norman
AU - Fahiminiya, Somayyeh
AU - Majewski, Jacek
AU - Glorieux, Francis H.
PY - 2013/1
Y1 - 2013/1
N2 - Background: Osteogenesis imperfecta (OI) type V is an autosomal dominant bone fragility disorder that we had described a decade ago. Recent research has shown that OI type V is caused by a recurrent c.-14C>T mutation in IFITM5. In the present study, we assessed all patients diagnosed with OI type V at our institutions for the presence of the IFITM5 mutation. Methods: IFITM5 exon 1 was analysed by Sanger sequencing in genomic DNA from 42 patients with OI type V (age: 2-67 years; 18 female). Results: The c.-14C>T mutation of IFITM5 was detected in all individuals. Indicators of disease severity varied widely: Height z-scores (n=38) ranged from -8.7 to -0.1, median -3.5. Median final height was 147cm in men (N=15) and 145cm in women (N=10). Lumbar spine areal bone mineral density z-scores in the absence of bisphosphonate treatment (n=29) were between -7.7 and -0.7, median -5.3. Scoliosis was present in 57%, vertebral compression fractures in 90% of patients. Conclusions: Even though the disease-causing mutation is identical among patients with OI type V, the interindividual phenotypic variability is considerable.
AB - Background: Osteogenesis imperfecta (OI) type V is an autosomal dominant bone fragility disorder that we had described a decade ago. Recent research has shown that OI type V is caused by a recurrent c.-14C>T mutation in IFITM5. In the present study, we assessed all patients diagnosed with OI type V at our institutions for the presence of the IFITM5 mutation. Methods: IFITM5 exon 1 was analysed by Sanger sequencing in genomic DNA from 42 patients with OI type V (age: 2-67 years; 18 female). Results: The c.-14C>T mutation of IFITM5 was detected in all individuals. Indicators of disease severity varied widely: Height z-scores (n=38) ranged from -8.7 to -0.1, median -3.5. Median final height was 147cm in men (N=15) and 145cm in women (N=10). Lumbar spine areal bone mineral density z-scores in the absence of bisphosphonate treatment (n=29) were between -7.7 and -0.7, median -5.3. Scoliosis was present in 57%, vertebral compression fractures in 90% of patients. Conclusions: Even though the disease-causing mutation is identical among patients with OI type V, the interindividual phenotypic variability is considerable.
UR - http://www.scopus.com/inward/record.url?scp=84872158413&partnerID=8YFLogxK
U2 - 10.1136/jmedgenet-2012-101307
DO - 10.1136/jmedgenet-2012-101307
M3 - Journal article
C2 - 23240094
AN - SCOPUS:84872158413
SN - 0022-2593
VL - 50
SP - 21
EP - 24
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 1
ER -